Skip to main content

Published locations for Daclizumab’s efficacy against MS tempered by adverse events

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Daclizumab’s efficacy against MS tempered by adverse events

User login

  • Reset your password
  • /content/daclizumabs-efficacy-against-ms-tempered-adverse-events
  • /familypracticenews/article/103508/multiple-sclerosis/daclizumabs-efficacy-against-ms-tempered
  • /internalmedicinenews/article/103508/multiple-sclerosis/daclizumabs-efficacy-against-ms-tempered
  • /internalmedicine/article/103508/multiple-sclerosis/daclizumabs-efficacy-against-ms-tempered-adverse
  • /neurology/article/103508/multiple-sclerosis/daclizumabs-efficacy-against-ms-tempered-adverse-events
  • /familymedicine/article/103508/multiple-sclerosis/daclizumabs-efficacy-against-ms-tempered-adverse
  • /clinicalneurologynews/article/103508/multiple-sclerosis/daclizumabs-efficacy-against-ms-tempered